Akero Therapeutics, Inc. (AKRO): Price and Financial Metrics
AKRO Price/Volume Stats
| Current price | $54.28 | 52-week high | $58.40 |
| Prev. close | $53.94 | 52-week low | $20.64 |
| Day low | $54.13 | Volume | 1,419,515 |
| Day high | $55.87 | Avg. volume | 1,470,265 |
| 50-day MA | $42.47 | Dividend yield | N/A |
| 200-day MA | $36.31 | Market Cap | 4.33B |
AKRO Stock Price Chart Interactive Chart >
Akero Therapeutics, Inc. (AKRO) Company Bio
Akero Therapeutics, Inc. operates as a biotechnology company. The firm specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. The company was founded by Jonathan Young and Timothy Rolph on January 24, 2017 and is headquartered in South San Francisco, CA.
AKRO Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
AKRO Price Returns
| 1-mo | 26.85% |
| 3-mo | 28.87% |
| 6-mo | 74.48% |
| 1-year | 154.48% |
| 3-year | 517.52% |
| 5-year | 125.70% |
| YTD | 95.11% |
| 2024 | 19.14% |
| 2023 | -57.39% |
| 2022 | 159.10% |
| 2021 | -18.02% |
| 2020 | 16.24% |